Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024

These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.

3 Battery Stocks to Turn $100,000 Into $1 Million: April 2024

Investing in battery stocks is like investing in the chip companies that make AI applications possible, and here are three names to consider

3 Stocks Soaring on Bullish Analyst Calls: Is It Time to Buy?

In a stock pickers market, analyst ratings are a good way to find stocks to buy heading into earnings season.

The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024

With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.